Argenx
ARGX
#571
Rank
S$48.77 B
Marketcap
$815.69
Share price
1.54%
Change (1 day)
22.97%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2024 : S$45.71 Million

According to Argenx 's latest financial reports the company's total debt is S$45.71 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2022-12-31S$16.65 M7.48%
2021-12-31S$15.49 M-1.36%
2020-12-31S$15.71 M42.16%
2019-12-31S$11.05 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31S$3.61 M-1.86%
2011-12-31S$3.68 M